Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Dendritic Cells and Metronomic Cyclophosphamide in Combination With Checkpoint Blockade for Relapsed High-Grade Gliomas in Children and Adolescents

NCT03879512 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT03879512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03879512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Dendritic Cells and Metronomic Cyclophosphamide in Combination With Checkpoint Blockade for Relapsed High-Grade Gliomas in Children and Adolescents
Lead sponsor
Wuerzburg University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
February 7, 2018
Completion date
July 31, 2024
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood glioblastoma